Neuronetics Inc <STIM.O>: B. Riley initiates coverage with buy rating; price target $5
STIM•Related News
Sonoco posts 2Q adjusted EPS USD 1.51 in Jefferies conference presentation
SON•
Elanco sets third-quarter results release, conference call
ELAN•
Quantum BioPharma wins FDA clearance for Lucid-MS Phase 2 trial
QNTM•
Vertu Motors opens second UK Leapmotor dealership in Crewe
STLA•
Exelixis falls as US FDA extends cancer drug review
EXEL•